Answers are grounded in this paper and cite their sources.
This clinic-based flyer details subcutaneous monoclonal antibody treatment for COVID-19, indicating potential effectiveness.
This mAb Colorado flyer describes a clinic-based example of subcutaneous mAb treatments for COVID-19 using visuals and text. Last updated fall 2021.
No takes yet. Share an insight, caveat, or question.
Lum et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: